ong term effects of definitive chemoradiotherapy on respiratory function tests in patients with locally advanced (non) small cell lung carcinoma

Withdrawn

• Conditions: (N)SCLC; lungcancer; 10029107

• Registration Number: NL-OMON42847
• Lead Sponsor: Haga ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 45

Inclusion Criteria

1. * 18 years of age
2. Histologically of cytologically confirmed diagnosis of (N)SCLC
3. Stage II/III non operable disease
4. Treatment with definite concurrent of sequential chemoradiation between November 2010 and November 2015
5. Lung function testing including DLCO measurement pre-treatment is available
6. Signed written informed consent

Exclusion Criteria

Not being able to have another lung function test done (due to death or poor condition)

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The change of lung function at least one year after chemoradiotherapy (long<br /><br>term changes) in our clinic.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>